Jan. 14 (UPI) --The U.S. Food and Drug Administration hopes "front-of-package" labeling will better improve the American population's health, the FDA announced. "Food should be a vehicle for ...

One of the best ways to improve the customer’s shopping experience is with package inserts; customer package inserts can be designed to improve the customer’s unpackaging experience greatly, which in ...

A Phase Ib/II dose escalation and expansion trial shows promising antitumor activity and durable responses with Talvey (talquetamab) plus Tecvayli (teclistamab) in the treatment of relapsed or ...

The 94-patient cohort had an overall response rate (ORR) of 78% across a range of doses of talquetamab (Talvey) and teclistamab (Tecvayli), including 80% of patients treated with the recommended ...

The FDA announced it has issued a new draft guidance on the use of artificial intelligence (AI) in supporting regulatory decision-making on a drug or biological product’s safety, effectiveness, or ...

Talquetamab-tgvs (Talvey) is a bispecific GPRC5D-directed CD3 T-cell engager. It is formulated as a solution for the subcutaneous route of administration. Talvey is indicated for the treatment of ...

The different query parameters above can be combined, so ?package=mysql&kibana.version=7.3.0 will return all mysql package versions which are compatible with 7.3.0 ...

Analysis from MonumenTAL-1 study showed patients with relapsed or refractory multiple myeloma treated with TALVEY™ were subsequently treated effectively with several classes of therapy, including ...